Artivion, Inc.

NYSE: AORT · Real-Time Price · USD
25.57
-0.05 (-0.20%)
At close: Sep 04, 2026, 3:59 PM
25.57
+0.00%
After-hours: 7:50 PM

The price, the headline numbers and the latest news, in one place.

Artivion, Inc. (AORT) Stock Price, Analysis & Data

-0.20% (1D)
Bid25.53
Market Cap1.25B
Revenue (ttm)471M
Net Income (ttm)-3.19M
1.25
-0.06
n/a
32.71
P/B (ttm)2.79
P/S (ttm)2.64
Earnings DateFeb 17, 2022
Ask26.5
Volume418,342
Avg. Volume (20D)736,144
Open25.37
Previous Close25.62
Day's Range25.25 - 25.69
52-Week Range19.16 - 48.25
Analystn/a
Price Target42 (64.25%)
Dividendsn/a
Ex-Dividend DateDec 9, 2015

About AORT

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent g...

Sector Healthcare
IPO Date Feb 12, 1993
Employees 1,800
Stock Exchange NYSE
Ticker Symbol AORT
Full Company Profile

Financial Performance

In 2025, Artivion's revenue was 441.33M, an increase of 13.59% compared to the previous year's 388.54M. Earnings were 9.77M, a decrease of -173.12%.

Financial Statements

Analyst Forecast

According to 8 analyst ratings, the average rating for AORT stock is "null". The 12-month stock price forecast is 42, which is upside of 64.25% from the latest price.

Stock Forecasts

Earnings Surprise

Artivion has released their quarterly earnings on Aug 6, 2026:
  • Revenue of $125.76M misses estimates by $0, with 11.32% YoY growth.
  • EPS of 0.13 exceeds estimates by 0.03, with -45.83% YoY decline.
Artivion, Inc. is scheduled to release its earnings on Feb 17, 2022, after market closes.
Analysts project revenue of ... Upgrade
Page 1 of 2